Zero-Covid Strategy: What’s Next?

Document Type : Viewpoint

Authors

1 Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China

2 Department of Clinical Medicine, The Third Clinical School, Guangzhou Medical University, Guangzhou, China

Keywords

Main Subjects

Full Text

Introduction

The goal of the strategy of control and maximum suppression (Zero-Covid) is to reduce virus transmission to near-zero levels and ultimately eliminate the virus within a specified geographic region.1 "Zero-Covid" means effective control of limited cases and zero transmission, that is, zero uncontrolled cases.2...(Read more...) 

References

  1. What is a Zero-COVID Strategy and How Can it Help Us Minimise the Impact of the Pandemic? https://www.isglobal.org/en_GB/-/-que-es-una-estrategia-de-covid-cero-y-como-puede-ayudarnos-a-minimizar-el-impacto-de-la-pandemia-. Accessed August 30, 2021.
  2. Skegg DC, Hill PC. Defining COVID-19 elimination. BMJ. 2021;374:n1794. doi:1136/bmj.n1794
  3. Preparing for our transition towards COVID resilience. https://www.moh.gov.sg/news-highlights/details/preparing-for-our-transition-towards-covid-resilience. Accessed August 30, 2021.
  4. Reconnecting New Zealanders to the world: Next steps. https://covid19.govt.nz/assets/reports/Independent-Advisory-Groups/Reconnecting-New-Zealanders-to-the-World/Reconnecting-New-Zealanders-to-the-World-Next-steps.pdf. Accessed August 30, 2021.
  5. Liang ST, Liang LT, Rosen JM. COVID-19: a comparison to the 1918 influenza and how we can defeat it. Postgrad Med J. 2021;97(1147):273-274. doi:1136/postgradmedj-2020-139070
  6. Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res. 2020;21(1):224. doi:1186/s12931-020-01479-w
  7. Dyer O. COVID-19: delta infections threaten herd immunity vaccine strategy. BMJ. 2021;374:n1933. doi:1136/bmj.n1933
  8. Forni D, Cagliani R, Pontremoli C, et al. Antigenic variation of SARS-CoV-2 in response to immune pressure. Mol Ecol. 2020. doi:1111/mec.15730
  9. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568-576. doi:1002/jmv.25748
  10. Johansson MA, Quandelacy TM, Kada S, et al. SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021;4(1):e2035057. doi:1001/jamanetworkopen.2020.35057
  11. COVID-19 Pandemic Planning Scenarios. https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html. Accessed August 30, 2021.
  12. Improving communications around vaccine breakthrough and vaccine effectiveness. https://contextcdn.washingtonpost.com/notes/prod/default/documents/8a726408-07bd-46bd-a945-3af0ae2f3c37/note/57c98604-3b54-44f0-8b44-b148d8f75165.#page=1. Accessed August 30, 2021.
  13. Pal K, Danda S. Stress, anxiety triggers and mental health care needs among general public under lockdown during COVID-19 pandemic: a cross-sectional study in India. Int J Ment Health Addict. 2021:1-12. doi:1007/s11469-021-00596-x
  14. Coronavirus (COVID-19) Vaccinations. https://ourworldindata.org/covid-vaccinations?country=. Accessed August 30, 2021.
  15. COVID-19 epidemic data statistics. http://2019ncov.chinacdc.cn/2019-nCoV/. Accessed August 30, 2021.
  16. Cheng ZJ, Zhan Z, Xue M, et al. Public health measures and the control of COVID-19 in China. Clin Rev Allergy Immunol. 2021:1-16. doi:1007/s12016-021-08900-2
  17. What does public health really mean? Lessons from covid-19. https://blogs.bmj.com/bmj/2021/07/26/what-does-public-health-really-mean-lessons-from-covid-19/. Accessed November 26, 2021.
  18. Karimi SE, Ahmadi S, SoleimanvandiAzar N. Inequities as a social determinant of health: Responsibility in paying attention to the poor and vulnerable at risk of COVID-19. J Public Health Res. 2021;10(1):1904. doi:4081/jphr.2021.1904

Files

History

  • Receive Date: 06 September 2021
  • Revise Date: 09 December 2021
  • Accept Date: 01 January 2022
  • First Publish Date: 02 January 2022

Share

How to cite

Statistics